Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3Jinnan Yue(Shanghai Jiao Tong University), Lu Xu(Shanghai Jiao Tong University)OncogeneApril 30, 201810.1038/s41388-018-0276-2Cited by 111SaveCiteExport RISWatch citationsRelated PapersAcquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF-κB pathway in EGFR-mutant NSCLC|Oncotarget|2017|34Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC)|Oncotarget|2015|32